Skip to main content
Erschienen in: World Journal of Surgery 3/2012

01.03.2012

Multiple Lymphatic Basin Drainage from Cutaneous Melanoma as a Prognostic Factor

verfasst von: Antonio Piñero, Carlos de Torre, Jorge Martínez-Escribano, Juana Campillo, Manuel Canteras, Francisco Nicolás

Erschienen in: World Journal of Surgery | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

There is some controversy in the literature regarding the possible prognostic value of cases of multiple lymphatic basin drainage (MLBD). The purpose of this work was to study the differences in prognosis depending on whether there is MLBD from primary cutaneous melanoma.

Methods

We conducted a cohort analysis from a prospective database, and 112 consecutive patients with cutaneous melanoma were included. Sentinel lymph node biopsy (SLNB) was done in all of them. MLBD was defined as the occurrence of two or more different nodal basins from the same lesion. The demographic and clinical data for cases with a single nodal drainage basin and MLBD were statistically compared using Fisher’s exact test, the χ2 test, or Mann–Whitney’s test according to the type of variables studied. Multivariate analysis also was performed on the disease-free survival rate using logistic regression analysis. The distribution of disease-free survival was determined using a Cox proportional risk model.

Results

Only gender (27% men and 8% women; P = 0.01) and the localization of the primary tumor in the trunk (P < 0.001) were associated with the presence of MLBD. It also was observed that the cases with a high Breslow thickness or with MLBD were only associated with a worse disease-free survival rate in cases with positive (P < 0.01 and P = 0.047, respectively) and negative (P < 0.011 and P = 0.019, respectively) SLNB.

Conclusions

This study suggests that both Breslow thickness and the presence of MLBD are statistically significant independent prognostic factors of disease-free survival in patients with cutaneous melanoma.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) Melanoma of the skin. In: AJCC cancer staging manual, 7th edn. New York, Springer-Verlag, pp 325–344 Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) Melanoma of the skin. In: AJCC cancer staging manual, 7th edn. New York, Springer-Verlag, pp 325–344
2.
Zurück zum Zitat Berk DR, Jonson DL, Uzieblo A et al (2005) Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997–2004. Arch Dermatol 141:1016–1023PubMedCrossRef Berk DR, Jonson DL, Uzieblo A et al (2005) Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997–2004. Arch Dermatol 141:1016–1023PubMedCrossRef
3.
Zurück zum Zitat Mandalá M, Invertí GL, Piazzalunga D et al (2009) Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. Eur J Cancer 45:2537–2545PubMedCrossRef Mandalá M, Invertí GL, Piazzalunga D et al (2009) Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. Eur J Cancer 45:2537–2545PubMedCrossRef
4.
Zurück zum Zitat Balch CM, Soong S, Ross MI et al (2000) Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Ann Surg Oncol 7:87–97PubMedCrossRef Balch CM, Soong S, Ross MI et al (2000) Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Ann Surg Oncol 7:87–97PubMedCrossRef
5.
Zurück zum Zitat Cormier JN, Xing Y, Ding M et al (2005) Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 23:6054–6062PubMedCrossRef Cormier JN, Xing Y, Ding M et al (2005) Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 23:6054–6062PubMedCrossRef
6.
Zurück zum Zitat Porter GA, Ross MI, Berman RS et al (2000) Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 7:256–261PubMedCrossRef Porter GA, Ross MI, Berman RS et al (2000) Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 7:256–261PubMedCrossRef
7.
Zurück zum Zitat Jimenez RE, Panageas K, Busam KJ et al (2005) Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma. J Clin Oncol 23:518–524PubMedCrossRef Jimenez RE, Panageas K, Busam KJ et al (2005) Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma. J Clin Oncol 23:518–524PubMedCrossRef
8.
Zurück zum Zitat McHugh JB, Su L, Griffith KA et al (2006) Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 13:1216–1223PubMedCrossRef McHugh JB, Su L, Griffith KA et al (2006) Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 13:1216–1223PubMedCrossRef
9.
Zurück zum Zitat Martel P, Garrido I, Ferron G et al (2010) An individualized prognosis for truncal melanoma ? A series of 77 cases. Bull Cancer 97:901–907PubMed Martel P, Garrido I, Ferron G et al (2010) An individualized prognosis for truncal melanoma ? A series of 77 cases. Bull Cancer 97:901–907PubMed
10.
Zurück zum Zitat Piñero A, Martínez-Escribano J, Nicolás F et al (2001) Selective sentinel node biopsy in melanoma using preoperative lymphoscintigraphy location and intraoperative detection gamma probe. Med Clin (Barc) 117:481–486 Piñero A, Martínez-Escribano J, Nicolás F et al (2001) Selective sentinel node biopsy in melanoma using preoperative lymphoscintigraphy location and intraoperative detection gamma probe. Med Clin (Barc) 117:481–486
11.
Zurück zum Zitat Morton DL, Thompson JF, Cochran AJ et al (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307–1317PubMedCrossRef Morton DL, Thompson JF, Cochran AJ et al (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307–1317PubMedCrossRef
12.
Zurück zum Zitat Leong SP, Morita ET, Sudmeyer M et al (2005) Heterogeneous patterns of lymphatic drainage to sentinel lymph nodes by primary melanoma from different anatomic sites. Clin Nucl Med 30:150–158PubMedCrossRef Leong SP, Morita ET, Sudmeyer M et al (2005) Heterogeneous patterns of lymphatic drainage to sentinel lymph nodes by primary melanoma from different anatomic sites. Clin Nucl Med 30:150–158PubMedCrossRef
13.
Zurück zum Zitat Dale PS, Foshag LJ, Wanek LA et al (1997) Metastasis of primary melanoma to two separate lymph node basins: prognostic significance. Ann Surg Oncol 4:13–18PubMedCrossRef Dale PS, Foshag LJ, Wanek LA et al (1997) Metastasis of primary melanoma to two separate lymph node basins: prognostic significance. Ann Surg Oncol 4:13–18PubMedCrossRef
14.
Zurück zum Zitat Wall JK, Florero M, Accortt NA et al (2007) Impact of multiple lymphatic channel drainage to a single nodal basin on outcomes in melanoma. Arch Surg 142:753–758PubMedCrossRef Wall JK, Florero M, Accortt NA et al (2007) Impact of multiple lymphatic channel drainage to a single nodal basin on outcomes in melanoma. Arch Surg 142:753–758PubMedCrossRef
15.
Zurück zum Zitat Vuylsteke RJ, van Leeuwen PA, Statius Muller MG et al (2003) Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol 21(6):1057–1065PubMedCrossRef Vuylsteke RJ, van Leeuwen PA, Statius Muller MG et al (2003) Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol 21(6):1057–1065PubMedCrossRef
16.
Zurück zum Zitat Zogakis TG, Essner R, Wang HJ et al (2005) Melanoma recurrence patterns after negative sentinel lymphadenectomy. Arch Surg 140(9):865–871PubMedCrossRef Zogakis TG, Essner R, Wang HJ et al (2005) Melanoma recurrence patterns after negative sentinel lymphadenectomy. Arch Surg 140(9):865–871PubMedCrossRef
17.
Zurück zum Zitat Koskivuo I, Talve L, Vihinen P et al (2007) Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Ann Surg Oncol 14(12):3566–3574PubMedCrossRef Koskivuo I, Talve L, Vihinen P et al (2007) Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Ann Surg Oncol 14(12):3566–3574PubMedCrossRef
18.
Zurück zum Zitat Federico AC, Chapgar AB, Ross MI et al (2008) Effect of multiple-nodal basin drainage on cutaneous melanoma. Arch Surg 143:632–638PubMedCrossRef Federico AC, Chapgar AB, Ross MI et al (2008) Effect of multiple-nodal basin drainage on cutaneous melanoma. Arch Surg 143:632–638PubMedCrossRef
Metadaten
Titel
Multiple Lymphatic Basin Drainage from Cutaneous Melanoma as a Prognostic Factor
verfasst von
Antonio Piñero
Carlos de Torre
Jorge Martínez-Escribano
Juana Campillo
Manuel Canteras
Francisco Nicolás
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 3/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1402-2

Weitere Artikel der Ausgabe 3/2012

World Journal of Surgery 3/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.